Ribosomal immunostimulation: assessment of studies evaluating its clinical relevance in the prevention of upper and lower respiratory tract infections in children and adults.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  BioDrugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14498765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrent Respiratory Tract Infections in Paediatric Patients

  2012cited by this paper
• An International Medico-Economic Survey of 2007 Children with Recurrent Nasopharyngitis and Acute Otitis Media

  2012cited by this paper
• Inhibition of Streptococcus pneumoniae Adhesion by Specific Salivary IgA after Oral Immunisation with a Ribosomal Immunostimulant

  2012cited by this paper
• Pharmacology of Ribosomal Immunotherapy

  2012cited by this paper
• The public health problem of acute respiratory illness in childcare.

  2001cited by this paper
• Meta-Analysis of Published Clinical Trials of a Ribosomal Vaccine (Ribomunyl®) in Prevention of Respiratory Infections

  2000cited by this paper
• Translocation of Ribosomal Immunostimulant Through an In Vitro–Reconstituted Digestive Barrier Containing M‐Like Cells

  2000cited by this paper
• Economic Evaluation of Ribosomal Immunotherapy in Patients with Chronic Ear, Nose and Throat and Respiratory Tract Infections

  1998cited by this paper
• Kinetics of specific salivary IgA responses in man after oral challenge by ribosomal immunostimulant.

  1997cited by this paper
• Effectiveness of ribosomal fractions ofKlebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction ofKp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis

  1997cited by this paper
• Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthma.

  1997cited by this paper
• Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.

  1997cited by this paper
• OM-8BV for COPD.

  1997cited by this paper
• Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life.

  1997cited by this paper
• Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media.

  1995cited by this paper
• Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine

  1995cited by this paper
• Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes.

  1994cited by this paper
• Economic Evaluation of Immunoprophylaxis in Children with Recurrent Ear, Nose and Throat Infections

  1994cited by this paper
• In vitro stimulation of polymorphonuclear cell adhesion by ribomunyl and antibiotic + ribomunyl combinations: effects on CD18, CD35 and CD16 expression.

  1993cited by this paper
• Evaluation of immune response of Waldeyer's tissues after local stimulation with bacterial ribosomal extracts. B, T and NK lymphocyte phenotype and function.

  1992cited by this paper
• Sinusitis in Infants and Children

  1992cited by this paper
• Immunostimulant effects on granulocyte functions during an acute respiratory infection.

  1992cited by this paper
• Bacterial ribosomal immunostimulants prime alveolar macrophages in vivo to produce interleukin 1 in vitro.

  1991cited by this paper
• Effect of an in vivo immunostimulant treatment on PMN functions: interaction with antibiotics in vitro.

  1991cited by this paper
• Effect of Oral Administration of Bacterial Extracts on the Bactericidal Capacity of Polymorphonuclear Leucocytes in Children with Recurrent Respiratory Infections

  1991cited by this paper
• Molecular-biological and immunological properties of ribosomal vaccines.

  1991cited by this paper
• Chemotactic cytokine gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae.

  1991cited by this paper
• Upper respiratory tract infections in young children: duration of and frequency of complications.

  1991cited by this paper
• The epidemiology of acute respiratory infections in children and adults: a global perspective.

  1990cited by this paper
• Interleukin-6 gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae.

  1990cited by this paper
• Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine.

  1990cited by this paper
• Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

  1989cited by this paper
• Stimulation of cytotoxic and non-cytotoxic functions of natural killer cells by bacterial membrane proteoglycans and ribosomes.

  1989cited by this paper
• Proliferative response of human T lymphocytes to a vaccinal preparation of ribosomes from Streptococcus pyogenes.

  1988cited by this paper
• Induction of Murine B Cell Proliferation and Immunoglobulin Synthesis by Some Bacterial Ribosomes

  1988cited by this paper
• On classifying otitis media as suppurative or nonsuppurative, with a suggested clinical schema.

  1987cited by this paper
• Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo‐controlled evaluation

  1984cited by this paper
• Immunogenic Activity of a Ribosomal Fraction Obtained from Mycobacterium tuberculosis

  1965cited by this paper

• Application of MRT-qPCR for pathogen detection of lower respiratory tract infection.

  2022cites this paper
• Immunostimulants for preventing respiratory tract infection in children: A systematic review and meta-analysis

  2022cites this paper
• Immunological Aspects of Diagnosis and Management of Childhood Tuberculosis

  2021cites this paper
• Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation

  2020cites this paper
• Immunity‐targeted approaches to the management of chronic and recurrent upper respiratory tract disorders in children

  2019cites this paper
• Prevention of allergies in children Author affiliation: Vishneva Elena Aleksandrovna, allergist-immunologist at the department of medical rehabilitation of children with allergic diseases and diseases of respiratory organs of the research institute of preventive pediatrics and medical rehabilitation

  2014cites this paper
• Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus

  2013cites this paper
• The increased expression of CD11c and CD103 molecules in the neutrophils of the peripheral blood treated with a formula of bacterial ribosomes and proteoglycans of Klebsiella pneumoniae.

  2012cites this paper
• Efficacy and safety of ribosome-component immune modulator for preventing recurrent respiratory infections in socialized children.

  2012cites this paper
• Aumento de la expresión de las moléculas CD11c y CD103 en neutrófilos de sangre periférica tratados con una formulación de ribosomas bacterianos y proteoglicanos de Klebsiella pneumoniae

  2012cites this paper
• Recurrent Respiratory Infections in Children – Definition, Diagnostic Approach, Treatment and Prevention

  2011cites this paper
• Useful C8 and T1 function seen immediately after a complete cervical spinal cord injury: report of 2 cases.

  2009cites this paper
• Ribosome-component immune modulation of respiratory tract infections in adults.

  2009cites this paper
• Rationale for the clinical use of a ribosome-component immune modulator.

  2009cites this paper
• Ribosome-component immune modulation of respiratory tract infections in children.

  2009cites this paper
• Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.

  2008cites this paper
• Immunostimulants in the prevention of respiratory infections

  2007influential citation
• Role of ribomunyl((r)) in the prevention of recurrent respiratory tract infections in adults : overview of clinical results.

  2006cites this paper
• Immunostimulants revisited: focus on the pharmacology of Ribomunyl.

  2006cites this paper
• Monocyte-derived DC Primed With TLR Agonists Secrete IL-12p70 in a CD40-dependent Manner Under Hyperthermic Conditions

  2006cites this paper
• Prevention of Recurrent Respiratory Tract Infections in Children Using a Ribosomal Immunotherapeutic Agent

  2006cites this paper
• Immunostimulants for preventing respiratory tract infection in children.

  2006cites this paper
• Effects of Oral Bacterial Immunotherapy in Children with Atopic Eczema/Dermatitis Syndrome

  2005cites this paper